This study aimed to evaluate the expression of RCAN2 in the liver of mice with hepatic steatosis and in the serum of NAFLD patients and to explore the relationship between serum RCAN2 levels and NAFLD. The gene discussed is RCAN2; the disease is metabolic dysfunction-associated steatotic liver disease.